Feedback to SSRN (Beta)
SSRN eLibrary Statistics:
Papers & Authors:
Abstracts:
484,509
Full Text Papers:
393,865
Authors:
226,776
Papers Received in Last 12 months:
68,968
Paper Downloads:
To date:
65,966,954
Last 12 months:
11,189,330
Last 30 days:
1,059,940
CiteReader: What's this?
Papers with
238,981
Total References:
8,480,523
Papers with Cites:
230,038
Total Citation
5,722,240
Papers with
77,812
Total Footnotes:
8,534,471
SSRN eLibrary Search Results
JEL Code: L65
55,878 Total downloads
Showing Papers 301 - 338 of 338
Sort By
Abstract Title, A-Z
Abstract Title, Z-A
Downloads, Ascending
Downloads, Descending
Date Posted, Ascending
Date Posted, Descending
Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks EFA 2004 Maastricht Meetings Paper; Universite de Liege Finance Working Paper No. 200405
Véronique Bastin
and
Georges Hubner
Date Posted: June 21, 2004270 downloads
Between- vs. Within-Patent Competition Regulation, Vol. 26, No. 3, pp. 42-48, Fall 2003
Tomas Philipson and
Carolanne Dai
Date Posted: March 02, 2004217 downloads
Bootleggers and Biotechs Regulation, Vol. 26, No. 2, pp. 12-14, Summer 2003
Henry I. Miller and
Gregory Conko
Date Posted: February 25, 200459 downloads
Pharmaceutical Marketing: Medical and Industry Biases Journal of Pharmaceutical Finance, Economics & Policy, Forthcoming
Paul H. Rubin
Date Posted: February 04, 2004514 downloads
Determinants of the Round-to-round Returns to Pre-IPO Venture Capital Investments in U.S. Biotechnology Companies
John R. M. Hand
Date Posted: January 08, 2004494 downloads
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry MIT Department of Economics Working Paper No. 03-33
Daron Acemoglu and
Joshua Linn
Date Posted: October 21, 2003459 downloads
Does Geography Matter for Science-Based Firms? Epistemic Communities and the Geography of Research and Patenting in Biotechnology
Michelle Gittelman
Date Posted: October 01, 2003308 downloads
Some Accounting and Technical Problems with Antidumping Trade Cases Involving a Transition Economy: A Russian Case Study
Robert W. McGee and
Galina Preobragenskaya
Date Posted: September 12, 2003634 downloads
New Drug Development: Estimating Entry from Human Clinical Trials FTC Bureau of Economics Working Paper No. 262
Christopher Adams
and
Van V. Brantner
Date Posted: September 12, 2003405 downloads
Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy UPF Working Paper No. 662
Antonio Cabrales
Date Posted: June 03, 2003322 downloads
Pharmacogenomics, Genetic Tests, and Patent-Based Incentives Boston Univ. School of Law Working Paper No. 03-09
Michael J. Meurer
Date Posted: May 14, 2003242 downloads
The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing FEEM Working Paper No. 48.2003; KSG Working Paper Series No. RWP03-014; Harvard Law School, Public Law Working Paper No. 61
Lori Snyder Bennear
,
Nolan H. Miller and
Robert N. Stavins
Date Posted: April 29, 2003209 downloads
Cyclical Market Power George Mason Law & Economics Research Paper No. 03-17
Amitai Aviram
Date Posted: April 23, 2003275 downloads
Earnings Management and Abnormal Returns: Evidence from the 1970-1972 Price Control Regulations Accounting and Finance, Vol. 43, pp. 1-19, 2003
Robert G. Bowman and
Farshid Navissi
Date Posted: March 18, 200317 downloads
Competition and Regulation Issues in the Pharmaceutical Industry Org. for Economic Co-operation & Dev., Best Practice Roundtables in Competition Policy No. 32
Darryl R. Biggar
Date Posted: July 30, 2002747 downloads
Distributing Products Under the Nonprofit Institutions Act: Price Discrimination,Arbitrage, and Fraud in the Pharmaceutical Industry Brigham Young University Law Review, Vol. 2001, No. 4, P. 1383, 2001
Dennis S. Corgill
Date Posted: May 07, 2002
Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry CEPR Discussion Paper No. 3162
Pedro L. Marin and
Georges Siotis
Date Posted: February 12, 200228 downloads
Credence Goods and Market Power: An Econometric Study on the Brazilian Pharmaceutical Industry IPEA Working Paper No. 846
Eduardo P.S. Fiuza and
Marcos de Barros Lisboa
Date Posted: February 03, 2002244 downloads
Pharmaceutical Prices and Political Activity MIT Department of Economics Working Paper No. 01-30
Sara Fisher Ellison and
Catherine D. Wolfram
Date Posted: September 19, 2001346 downloads
Environmental Management in the Brazilian Chemical Sector
Ana Lucia Guedes and
Alex Faria
Date Posted: August 17, 200187 downloads
Countervailing Power in Wholesale Pharmaceuticals MIT Dept. of Economics Working Paper No. 01-27
Sara Fisher Ellison and
Christopher M. Snyder
Date Posted: July 25, 2001638 downloads
Avoiding Suboptimal Behavior in Intellectual Asset Transactions: Economic and Organizational Perspectives on the Sale of Knowledge Harvard Law and Economics Discussion Paper No. 330
Gavin Clarkson
Date Posted: July 21, 2001354 downloads
Gradual Incorporation of Information: Pharmaceutical Stocks and the Evolution of Clinton's Health Care Reform Journal of Law and Economics, Vol. 44, No. 1, April 2001
Sara Fisher Ellison and
Wallace P. Mullin
Date Posted: April 02, 2001
Corporate Restructuring and R&D: A Panel Data Analysis for the Chemical Industry IGIER Working Paper No. 173
Ashish Arora ,
Marco Ceccagnoli and
Marco Da Rin
Date Posted: March 01, 2001435 downloads
Equilibrium Price Dispersion in Retail Markets for Prescription Drugs Journal of Political Economy, Vol. 108, No. 4, 2000
Alan T. Sorensen
Date Posted: December 28, 2000
Does Regulation Drive Out Competition in Pharmaceutical Markets? Journal of Law and Economics, Vol. 43, No. 2, October 2000
Patricia M. Danzon and
Li-Wei Chao
Date Posted: July 11, 2000
Regulatory Threats and Political Vulnerability Journal of Financial Research
Robert G. Bowman ,
Farshid Navissi and
Richard C. Burgess
Date Posted: April 11, 2000
Evolutionary Innovations: Learning, Entrepreneurship and the Dynamics of the Firm Journal of Evolutionary Economics, Vol. 8, Issue 2, 1998
Maureen McKelvey
Date Posted: October 26, 1998
What Prices Can Tell Us About the Market for Antibiotics MIT Department of Economics Working Paper No. 98-10
Sara Fisher Ellison
Date Posted: September 15, 1998
Managerial Determinants of Industrial R&D Performance: An Analysis of the Global Chemicals/Materials Industry
Edward B. Roberts and
Paulo Roberto Belloti
affiliation not provided to SSRN
Date Posted: August 25, 1998
Geographically Localized Knowledge: Spillovers or Markets? Economic Inquiry, Vol. 36, No. 1, January 1998
Lynne G. Zucker ,
Michael R. Darby and
Jeff S. Armstrong
Date Posted: July 09, 1998
Searching for the Profit in Pollution Prevention: Case Studies in the Corporate Evaluation of Environmental Opportunities Discussion Paper 98-30
James Boyd
Date Posted: May 07, 1998361 downloads
The Impact of Process Control Technology on Turkish Chemical Industry
Dilek Cetindamar
Date Posted: December 01, 199779 downloads
The Economic Sense of Royalty Rates
Elli Malki
Date Posted: August 06, 1997477 downloads
The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules RAND JOURNAL OF ECONOMICS, Vol. 28, No. 2, 1997
Fiona M. Scott Morton
Date Posted: June 25, 1997
Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins RAND JOURNAL OF ECONOMICS, Vol. 28, No. 3, Autumn 1997
Sara Fisher Ellison ,
Iain M. Cockburn ,
Zvi Griliches and
Jerry A. Hausman
Date Posted: March 12, 1997
Products Liability and Prescription Drug Prices in Canada and the United States Journal of Law and Economics, April 1997.
Richard L. Manning
Date Posted: October 16, 1996
Site Hazard, Settlement Activity, and Superfund Liability Valuation
Katherine Campbell ,
Naomi S. Soderstrom and
Stephan Sefcik
Date Posted: June 17, 1996
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
FAQ
Terms of Use
Privacy Policy
Copyright
8.548 seconds
